Nipent Lyophilisate For Solution For Injection 10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Nipent: Lyophilisate for solution for injection (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

PENTOSTATIN (PEN toe stat in) is a chemotherapy drug. It interferes with the growth of cancer cells. It is usually used to treat hairy-cell leukemia.

In-Depth Information
Select a Medication

Nipent 10mg Powder for Injection

NDC: 627010800
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Hairy-cell Leukemia

Sometimes used for but not FDA approved for the following conditions:
Mycosis Fungoides, Stem Cell Transplant Preparation, Graft-versus-host Disease (GVHD) Prophylaxis, Chronic Lymphocytic Leukemia (CLL), Cutaneous T-cell Lymphoma (CTCL), Graft-versus-host Disease (GVHD)

Storage Information
Refrigerate (between 36 and 46 degrees F)
Nipent 10mg Powder for Injection

Reported Side Effects for Nipent 10mg Powder for Injection

Metallic Taste Incidence:
<3.0%*
Severity: MILD
Onset: EARLY
Dysarthria Incidence:
<3.0%*
Severity: MODERATE
Onset: DELAYED
Breathing Difficulties Incidence:
<3.0%*
Severity: SEVERE
Onset: RAPID
Incoordination Incidence:
<3.0%*
Severity: MODERATE
Onset: DELAYED
Loss Of Memory Incidence:
<3.0%*
Severity: MODERATE
Onset: DELAYED
Hemolytic-uremic Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Secondary Malignancy Incidence:
<3.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Blood Vessels Incidence:
<3.0%*
Severity: SEVERE
Onset: DELAYED
Moschcowitz Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Fainting Incidence:
<3.0%*
Severity: MILD
Onset: EARLY
Convulsions Incidence:
<3.0%*
Severity: SEVERE
Onset: DELAYED
Infection Incidence:
<38.0%*
Severity: MILD
Onset: DELAYED
Difficulty Swallowing Incidence:
<3.0%*
Severity: MODERATE
Onset: DELAYED
Dry Eyes Incidence:
<3.0%*
Severity: MILD
Onset: EARLY
Balance Problems Incidence:
<3.0%*
Severity: MILD
Onset: EARLY
Ringing In Ears Incidence:
<3.0%*
Severity: MILD
Onset: DELAYED
Blood Clot In Lung Incidence:
<3.0%*
Severity: SEVERE
Onset: DELAYED
Light Sensitivity Incidence:
<3.0%*
Severity: MODERATE
Onset: EARLY
Visual Impairment Incidence:
<3.0%*
Severity: SEVERE
Onset: EARLY
Retinopathy Incidence:
<3.0%*
Severity: SEVERE
Onset: DELAYED
Kidney Failure Incidence:
<3.0%*
Severity: SEVERE
Onset: DELAYED
Photosensitivity Incidence:
<3.0%*
Severity: MILD
Onset: DELAYED
Irritated Blood Vessels Incidence:
<3.0%*
Severity: MODERATE
Onset: RAPID
Red Spotted Rash Incidence:
<3.0%*
Severity: MILD
Onset: DELAYED
Ear Pain Incidence:
<3.0%*
Severity: MILD
Onset: EARLY
Muscle Paralysis Incidence:
<3.0%*
Severity: SEVERE
Onset: DELAYED
Rash With Pustules Incidence:
<67.0%*
Severity: MILD
Onset: EARLY
Decreased Sexual Desire Incidence:
<3.0%*
Severity: MILD
Onset: DELAYED
Laryngeal Edema Incidence:
<3.0%*
Severity: SEVERE
Onset: RAPID
Secretion Of Tears Incidence:
<3.0%*
Severity: MILD
Onset: EARLY
Impotence (erectile Dysfunction) Incidence:
<3.0%*
Severity: MODERATE
Onset: DELAYED
Hyperkinesis Incidence:
<3.0%*
Severity: MILD
Onset: DELAYED
Hostility Incidence:
<3.0%*
Severity: MODERATE
Onset: EARLY
Deafness Incidence:
<3.0%*
Severity: SEVERE
Onset: DELAYED
Hallucinations Incidence:
<3.0%*
Severity: MODERATE
Onset: EARLY
Inflamed Tongue Incidence:
<3.0%*
Severity: MODERATE
Onset: EARLY
Skin Redness Incidence:
<67.0%*
Severity: MODERATE
Onset: EARLY
Emotional Lability Incidence:
<3.0%*
Severity: MILD
Onset: EARLY
Gout Incidence:
<3.0%*
Severity: MODERATE
Onset: DELAYED
Heart Failure Incidence:
<3.0%*
Severity: SEVERE
Onset: DELAYED
Hemolytic Anemia Incidence:
<3.0%*
Severity: SEVERE
Onset: DELAYED
High Calcium Levels Incidence:
<3.0%*
Severity: MODERATE
Onset: DELAYED
High Blood Pressure Incidence:
<3.0%*
Severity: MODERATE
Onset: EARLY
Low Blood Sodium Levels Incidence:
<3.0%*
Severity: MODERATE
Onset: DELAYED
Constipation Incidence:
<3.0%*
Severity: MODERATE
Onset: DELAYED
Suddenly Stopped Heart Incidence:
<3.0%*
Severity: SEVERE
Onset: EARLY
Slow Heart Beat Incidence:
<3.0%*
Severity: SEVERE
Onset: RAPID
Heart Block Incidence:
<3.0%*
Severity: SEVERE
Onset: EARLY
Bowel Obstruction Incidence:
<3.0%*
Severity: SEVERE
Onset: DELAYED
Aplastic Anemia Incidence:
<3.0%*
Severity: SEVERE
Onset: DELAYED
Chest Pain Incidence:
<3.0%*
Severity: MODERATE
Onset: EARLY
No Menstrual Periods Incidence:
<3.0%*
Severity: MILD
Onset: DELAYED
Lazy Eye Incidence:
<3.0%*
Severity: MODERATE
Onset: DELAYED
Kidney Stones Incidence:
<3.0%*
Severity: MODERATE
Onset: DELAYED
Fluid Around The Heart Incidence:
<3.0%*
Severity: SEVERE
Onset: DELAYED
Hair Loss Incidence:
<3.0%*
Severity: MILD
Onset: DELAYED
Inflamed Nerve Incidence:
<3.0%*
Severity: MODERATE
Onset: DELAYED
Acne Incidence:
<3.0%*
Severity: MILD
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
2.0-19.0%*
Severity: MODERATE
Onset: DELAYED
Gas Incidence:
3.0-10.0%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
3.0-10.0%*
Severity: MODERATE
Onset: EARLY
Confusion Incidence:
3.0-10.0%*
Severity: MODERATE
Onset: EARLY
Lightheadedness Incidence:
3.0-10.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
3.0-10.0%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
3.0-10.0%*
Severity: MILD
Onset: EARLY
Depression Incidence:
3.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Paresthesias Incidence:
3.0-10.0%*
Severity: MILD
Onset: DELAYED
Nervousness Incidence:
3.0-10.0%*
Severity: MILD
Onset: DELAYED
Joint Pain Incidence:
3.0-6.0%*
Severity: MILD
Onset: DELAYED
Inability To Sleep Incidence:
3.0-10.0%*
Severity: MILD
Onset: EARLY
Hives Incidence:
3.0-10.0%*
Severity: MILD
Onset: RAPID
Low Blood Pressure Incidence:
3.0-10.0%*
Severity: MODERATE
Onset: RAPID
Gum Inflammation Incidence:
3.0-10.0%*
Severity: MILD
Onset: DELAYED
Dry Skin Incidence:
3.0-10.0%*
Severity: MILD
Onset: DELAYED
No White Blood Cells Incidence:
3.0-10.0%*
Severity: SEVERE
Onset: DELAYED
Bleeding Incidence:
3.0-10.0%*
Severity: MODERATE
Onset: EARLY
Fluid Retention Incidence:
3.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
4.0-16.0%*
Severity: MILD
Onset: EARLY
Boils Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Conjunctivitis Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Mouth Ulcers Incidence:
5.0-12.0%*
Severity: MODERATE
Onset: DELAYED
Sinus Infection Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
Low Platelet Count Incidence:
6.0-32.0%*
Severity: MODERATE
Onset: DELAYED
Sore Throat Incidence:
8.0%*
Severity: MILD
Onset: DELAYED
Anemia Incidence:
8.0-35.0%*
Severity: MODERATE
Onset: DELAYED
Shortness Of Breath Incidence:
8.0-11.0%*
Severity: MODERATE
Onset: EARLY
Excessive Sweating Incidence:
8.0-10.0%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
10.0-12.0%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
10.0-21.0%*
Severity: MILD
Onset: RAPID
Headache Incidence:
11.0-19.0%*
Severity: MILD
Onset: EARLY
Chills Incidence:
11.0-19.0%*
Severity: MILD
Onset: RAPID
Rhinitis Incidence:
11.0%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
11.0-19.0%*
Severity: MILD
Onset: EARLY
Decreased Appetite Incidence:
13.0-16.0%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
15.0-17.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
17.0-20.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
22.0-63.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cell Counts Incidence:
22.0-60.0%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
26.0-43.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
29.0-42.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
42.0-46.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
53.0-63.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Nipent

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5